Company overview
Qlucore provides software solutions for precision medicine, including Qlucore Omics Explorer, Qlucore Insights, and Qlucore Diagnostics, enabling multi-omics data analysis, AI-powered machine learning classifiers for disease subtyping, and companion diagnostics development. Their platform supports clinical diagnostics like RNA-seq-based subtype classification for B-cell leukemias (BCP-ALL), certified under IVDR with CE-mark. It facilitates research, drug development, and scalable deployment across cancer types through visualization-based tools and plug-in models.
Qlucore is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing, Software & Digital Lab partner serving United States & Americas. Core focus areas include qlucore, precision medicine, omics software, companion diagnostics, ai classifiers.
Industry categories: Diagnostics & Testing, Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Qlucore include Software, Diagnostic — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://qlucore.com/
- Categories
- Diagnostics & Testing, Software & Digital Lab
- Markets served
- United States & Americas
- Keywords
- qlucore, precision medicine, omics software, companion diagnostics, ai classifiers
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Qlucore's key software products for pharma R&D and diagnostics?
- Qlucore offers Qlucore Omics Explorer for research data analysis, Qlucore Insights for interpretation, and Qlucore Diagnostics for clinical use, supporting multi-omics, AI classifiers, and companion diagnostics development.
- What regulatory certifications does Qlucore Diagnostics hold?
- Qlucore Diagnostics for BCP-ALL is certified under the IVDR regulation and CE-marked, using RNA-seq for gene expression subtype classification and gene fusion analysis.
- What capabilities does Qlucore provide for precision oncology and companion diagnostics?
- Qlucore enables disease-specific AI-based machine learning classifiers for subtyping, integrated with NGS workflows, visualizations, and report generation for clinical tests and CDx across cancer types.
Related editorial coverage
- Bio-IT World Conference: Oncology Highlights - Day 1
- BioMed Israel 2024: Key Innovations and US Partnerships
- US-Japan Healthcare Conf: Key Takeaways for 2026
- Oncology Data Landscape 2026: Key Trends & Upcoming Readouts
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- Brazilian Oncology Market: Growth of Precision Medicine & Biomarker Testing
Explore lab tools and QA/QC resources for R&D teams.
